Author

D. Birnbaum

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

F. Bertucci· 2 shared P. Finetti· 2 shared A. Daulat· 1 shared A. Iwama· 1 shared A. Mazuel· 1 shared D. Revinski· 1 shared E. Duprez· 1 shared F. Luton· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

F. Bertucci

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-cell multi-omics analyses reveal EZH2 as a main driver of retinoic acid resistance in PLZF-RARA leukemia.

M. Poplineau, N. Platet, A. Mazuel, L. Herault, S. Koide, W. Kuribayashi, N. Carbuccia, L. N'Guyen, J. Vernerey, M. Oshima, D. Birnbaum, A. Iwama, E. Duprez

This study identifies EZH2 as a driver of retinoic acid resistance in PLZF-RARA leukemia using single-cell multi-omics analyses and shows targeting pan-EZH2 activities can eliminate resistant cells.

bioRxiv · Jan 4, 2022 · PreprintCancer Biology

EFA6B regulates a stop signal for collective invasion in breast cancer

R. Fayad, M. Vazquez Rojas, M. Partisani, P. Finetti, S. Dib, V. Virolle, O. Cabaud, M. Lopez, D. Birnbaum, F. Bertucci, M. Franco, F. Luton

This study shows that EFA6B loss promotes collective invasion in breast cancer by reprogramming cell-ECM interactions and activating CDC42, as seen in patient-derived invasive tumors.

bioRxiv · Mar 19, 2020Cancer Biology

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

A. Daulat, P. Finetti, D. Revinski, M. S. Wagner, L. Camoin, S. Audebert, D. Birnbaum, L. Kodjabachian, J.-P. Borg, F. Bertucci

The paper identifies PRICKLE1 and ECT2 as poor-prognosis markers in triple-negative breast cancer by showing their interaction and role in RAC1 signaling.

bioRxiv · Dec 14, 2018Cancer Biology